CRMD · CorMedix Inc
United States · RS rating 34 · As of 2026-10-14
| Price | 7.39 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 38 / 30 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 24 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -87.3% |
| Sales growth Q/Q | +23.3% |
| Distance from 52-week high | +42.0% |
| Market cap (USD) | $579.4M |